Search Results - "Rajadhyaksha, Viraj"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Managing diabetes patients in India: Is the future more bitter or less sweet? by Rajadhyaksha, Viraj

    Published in Perspectives in clinical research (01-01-2018)
    “…[...]the selection of treatment options would depend on the long-term sustainability of glycemic control, safety, especially in terms of hypoglycemia and…”
    Get full text
    Journal Article
  2. 2

    Medical affairs post-COVID 19: Are we ready to take the baton? by Rajadhyaksha, Viraj

    Published in Perspectives in clinical research (01-07-2020)
    “…The spread of coronavirus epidemic has resulted in a change in the work schedule for Medical affairs professionals in the pharmaceutical industry. There has…”
    Get full text
    Journal Article
  3. 3

    Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort by Hafidh, Khadija, Malek, Rachid, Al-Rubeaan, Khalid, Kok, Adri, Bayram, Fahri, Echtay, Akram, Rajadhyaksha, Viraj, Hadaoui, Ahmed

    Published in Frontiers in endocrinology (Lausanne) (09-08-2022)
    “…We evaluated the prevalence of vascular complications and associated risk factors in individuals with type 2 diabetes mellitus (T2DM) initiating second-line…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Conducting feasibilities in clinical trials: an investment to ensure a good study by Rajadhyaksha, Viraj

    Published in Perspectives in clinical research (01-07-2010)
    “…Conducting clinical trial feasibility is one of the first steps in clinical trial conduct. This process includes assessing internal and environmental capacity,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Evolving role of pharmaceutical physicians in the industry: Indian perspective by Patil, Anant, Rajadhyaksha, Viraj

    Published in Perspectives in clinical research (01-01-2012)
    “…The Indian pharmaceutical industry, like any other industry, has undergone significant change in the last decade. The role of a Medical advisor has always been…”
    Get full text
    Journal Article
  10. 10

    A real-world registry of patients with metastatic castration-resistant prostate cancer (mCRPC): REMPRO study by Gonzalez, Francisco, Kodagali, Rohit, Tung, Teresa, Masoud, Mohamed, Rajadhyaksha, Viraj

    Published in Journal of clinical oncology (20-02-2023)
    “…TPS286 Background: Rapidly expanding treatment armamentarium for mCRPC calls for an appropriate patient and treatment selection, and sequencing with existing…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Place of Sodium–glucose Cotransporter-2 inhibitors in East Asian subjects with Type 2 Diabetes Mellitus: Insights into the management of Asian phenotype by Lim, Lee Ling, Tan, Alexander Tong Boon, Moses, Kevin, Rajadhyaksha, Viraj, Chan, Siew Pheng

    Published in Journal of diabetes and its complications (01-02-2017)
    “…Abstract The burden of type 2 diabetes (T2DM) in East Asia is alarming. Rapid modernization and urbanization has led to major lifestyle changes and a…”
    Get full text
    Journal Article
  13. 13

    Developing Medical Affairs Leaders Who Create the Future by Bedenkov, Alexander, Rajadhyaksha, Viraj, Beekman, Maarten, Moreno, Carmen, Fong, Pei-Chieh, Agustin, Lyra, Odell, Sarah

    Published in Pharmaceutical medicine (01-10-2020)
    “…Medical affairs has evolved over recent years from a support, to a partner, to a strategic leadership function. In the future, there will be significant…”
    Get full text
    Journal Article
  14. 14

    The 7+ Habits of Highly Effective Medical Directors by Bedenkov, Alexander, Rajadhyaksha, Viraj, Moreno, Carmen, Goncalves, Susana, Fong, Pei-Chieh, Ipatov, Andrey, Erdal, Berin

    Published in Pharmaceutical medicine (01-09-2021)
    “…Medical Directors in the pharmaceutical industry are responsible for fulfilling multiple roles, including scientific expert, conscience keeper and people…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial by Mootsikapun, Piroon, Hsueh, Po-Ren, Talwar, Deepak, Co, Vilma M, Rajadhyaksha, Viraj, Ong, Moh-Lim

    Published in BMC infectious diseases (15-05-2013)
    “…Candidemia is a significant cause of morbidity and mortality in hospitalized patients, particularly in Asia. Anidulafungin has been reported to be an effective…”
    Get full text
    Journal Article